ADDERALL (CII)
ADDERALL ® 5 MG IS A WHITE TO ... therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Amphetamines are thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.
Download ADDERALL (CII)
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Tablets, Antidepressant, Effexor, Venlafaxine hydrochloride, Venlafaxine, Hydrochloride
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
Administration, Drug, Food and drug administration, Food, Cytotec
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
Clinical, Capsule, Hydrochloride, Namenda xr, Namenda, Memantine hydrochloride, Memantine
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
Drug, Food, Food and drug, Only, Intravenous, For intravenous use only
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
Alcohols, Neonates, Contains, In neonates contains benzyl, Benzyl, In neonates contains benzyl alcohol
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Administration, Drug, Food and drug administration, Food, Only, Venofer
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
Attention-Deficit/ Hyperactivity Disorder (ADHD): Parents ...
www.aacap.orgmedication or other treatment until they understand your child’s mental health challenges and have made a diagnosis. The best way to do this is with a thorough,
Reference ID: 3416347
www.accessdata.fda.govADDERALL XR® is indicated for the treatment of attention deficit hyperactivity disorder (ADHD). The efficacy of ADDERALL XR in the treatment of ADHD was established on the basis of two controlled trials in children aged 6 to 12, one controlled trial in adolescents aged 13 to 17, ...
Timeline of ADHD prevalence, medications, and diagnostic ...
www.cdc.govAdderall Dextrostat, Dexadrine . Concerta, Methylin ER . Methylin . oral/chewable . Intuniv . Focalin, Adderall XR, Metadate CD . Focalin XR . Daytrana . DSM-I “Minimal Brain Dysfunction” DSM-II “Hyperkinetic Reaction of Childhood” DSM-III “ADD with or without hyperactivity” DSM-III-R “ADHD, undifferentiated ADD” DSM-IV/DSM-IV-TR
Stimulant and Related Medications: U.S. Food and Drug ...
www.cms.govStimulant and Related Medications: U.S. Food and Drug Administration-Approved Indications and Dosages for Use in Adults The therapeutic dosing recommendations for stimulant and related medications are based on U.S. Food and Drug Administration (FDA)-approved
Drug Fact Sheet: Amphetamines - DEA
www.dea.govto treat attention-deficit hyperactivity disorder (ADHD). WHAT IS THEIR ORIGIN? Amphetamines were first marketed in the 1930s as Benzedrine in an over-the-counter inhaler to treat nasal congestion. By 1937 amphetamines were available by prescription in tablet form and were used in the treatment of the sleeping disorder narcolepsy and ADHD.
Commonly Prescribed Psychotropic Medications
www.healthpartners.comdextroamphetamine Adderall, Dexedrine ADD diazepam Valium anxiety divalproex sodium Depakote bipolar disorder doxepin Adapin, Sinequan depression (tricyclic) escitalopram Lexapro depression (SSRI), anxiety fluoxetine Prozac depression (SSRI), OCD, panic fluphenazine Prolixin, Prolixin Decanoate schizophrenia (typical)
Attention-Deficit/Hyperactivity Disorder (ADHD)
www.mirecc.va.govIt is a neurological brain disorder that is ... Adderall, Dexedrine, or Strattera (an effective non-stimulant). The effects of these medications are typically felt within 30-60 minutes of taking the medication. Increasing, decreasing, or terminating medication is determined on a …
Disorders, Adhd, Attention, Deficit, Hyperactivity, Attention deficit hyperactivity disorder, Adderall